AGTC posts $5.2 million quarterly loss

Applied Genetic Technologies Corporation reported a net loss of $5.2 million in the quarter ended Dec. 31, 2017, compared with a net income of $1.8 million in the same quarter of 2016, according to a press release.
The company had total revenue of $4.9 million in the quarter compared with $10.9 million the previous year.
Quarterly research and development costs increased from $6 million in 2016 to $7.7 million in 2017, which was partially attributed to increased spending on the company’s clinical programs and increased employee-related expenses.
General and administrative (Read more...)

Full Story →